Concepedia

Impact of combined secondary prevention therapy after myocardial infarction: Data from a nationwide French registry

Nicolas Danchin, Jean‐Pierre Cambou, G Hanania, Zena Kadri, N Genès, Jean‐Marc Lablanche, Didier Blanchard, L Vaur, Pierre Clerson, Pascal Guéret

American Heart Journal · 2005 · 54 citations · 13 references

DOI

Concepts

References

13

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

New England Journal of Medicine · 2000 · 8.7K citations · Full text

, , +16

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Anders Olsson, John J.V. McMurray, G Thorgeirsson et al. · The Lancet · 1994 · 8.5K citations

, , +13

The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

Frank M. Sacks, Marc A. Pfeffer, Lemuel A. Moyé et al. · New England Journal of Medicine · 1996 · 7.5K citations · Full text

, , +16

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial

The Lancet · 2002 · 7K citations

, , +13

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

New England Journal of Medicine · 1998 · 5.3K citations · Full text

, , +15